1,482 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Acquired by First National Bank of Hutchinson

First National Bank of Hutchinson purchased a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 1,482 shares of the medical equipment provider's stock, valued at approximately $734,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Proficio Capital Partners LLC increased its stake in shares of Intuitive Surgical by 2.9% in the 1st quarter. Proficio Capital Partners LLC now owns 1,872 shares of the medical equipment provider's stock worth $927,000 after acquiring an additional 52 shares in the last quarter. KLP Kapitalforvaltning AS boosted its holdings in shares of Intuitive Surgical by 3.0% during the 1st quarter. KLP Kapitalforvaltning AS now owns 123,162 shares of the medical equipment provider's stock valued at $60,998,000 after acquiring an additional 3,600 shares during the last quarter. Universal Beteiligungs und Servicegesellschaft mbH boosted its holdings in Intuitive Surgical by 4.4% in the first quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 335,757 shares of the medical equipment provider's stock worth $166,290,000 after purchasing an additional 14,002 shares during the last quarter. Y Intercept Hong Kong Ltd bought a new stake in shares of Intuitive Surgical during the 1st quarter valued at about $4,543,000. Finally, Crystal Rock Capital Management bought a new position in Intuitive Surgical in the first quarter worth approximately $1,449,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Performance

ISRG stock traded down $13.34 during midday trading on Thursday, hitting $488.61. 2,604,316 shares of the company's stock were exchanged, compared to its average volume of 1,810,609. The stock's fifty day moving average price is $532.65 and its 200-day moving average price is $535.75. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The company has a market cap of $175.13 billion, a PE ratio of 68.15, a price-to-earnings-growth ratio of 5.32 and a beta of 1.64.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.93 by $0.26. The business had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%. The firm's quarterly revenue was up 21.4% on a year-over-year basis. During the same period in the previous year, the company posted $1.78 EPS. On average, analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on ISRG. Evercore ISI upped their price target on Intuitive Surgical from $470.00 to $550.00 and gave the stock an "in-line" rating in a research note on Tuesday, July 8th. Deutsche Bank Aktiengesellschaft downgraded Intuitive Surgical from a "hold" rating to a "sell" rating and dropped their price target for the stock from $515.00 to $440.00 in a research report on Monday, June 9th. Robert W. Baird lowered their target price on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. BTIG Research increased their price objective on Intuitive Surgical from $566.00 to $571.00 and gave the company a "buy" rating in a report on Wednesday. Finally, Citigroup reaffirmed a "buy" rating and issued a $650.00 price target (up previously from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have given a buy rating to the stock. Based on data from MarketBeat, Intuitive Surgical currently has a consensus rating of "Moderate Buy" and a consensus price target of $592.05.

Insider Buying and Selling

In other news, EVP Gary Loeb sold 1,700 shares of the company's stock in a transaction on Friday, April 25th. The shares were sold at an average price of $513.18, for a total value of $872,406.00. Following the sale, the executive vice president directly owned 2,245 shares of the company's stock, valued at approximately $1,152,089.10. This represents a 43.09% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, SVP Mark Brosius sold 216 shares of the firm's stock in a transaction on Friday, June 6th. The stock was sold at an average price of $563.11, for a total transaction of $121,631.76. Following the completion of the sale, the senior vice president owned 907 shares of the company's stock, valued at $510,740.77. The trade was a 19.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 4,998 shares of company stock valued at $2,611,577. Company insiders own 0.70% of the company's stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.